コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 Campylobacter jejuni expressing a GD1a-like, sialylated glycan.
2 und that conserved small noncoding RNAs bear sialylated glycans.
3 generally not microbial cell surfaces, have sialylated glycans.
4 hat lack coding nucleic acids but do possess sialylated glycans.
5 he seal H3 bound preferentially to alpha-2,3 sialylated glycans.
6 teroids, phospholipids, phosphopeptides, and sialylated glycans.
7 the ionization responses for all neutral and sialylated glycans.
8 mproved desorption of both large and heavily sialylated glycans.
9 protein exhibiting no detectable binding to sialylated glycans.
10 s as well as the growth of C. perfringens on sialylated glycans.
11 MCs depends on alpha1,3-fucosylated, but not sialylated, glycans.
12 mutation on HA resulted in a mixed alpha2-3 sialylated glycan (alpha2-3)/alpha2-6 binding virus (NY1
13 lutinin (HA) to long (chain length) alpha2-6 sialylated glycan (alpha2-6) receptors on the human uppe
14 evealed that IAV binds to sialylated and non-sialylated glycans and binding is not concordant with re
15 inding, with Gal-8N recognizing sulfated and sialylated glycans and Gal-8C recognizing blood group an
17 in SK1 SRR adhesin affects interactions with sialylated glycans and glycoproteins, we determined high
19 The reovirus attachment protein sigma1 binds sialylated glycans and proteinaceous receptors to mediat
20 --enables specific binding of HA to alpha2-6 sialylated glycans and that recognition of this topology
21 re substituted with a variety of neutral and sialylated glycans and the spectra obtained were such th
22 ereas Gal-1 bound alpha2-3- but not alpha2-6-sialylated glycans, and Gal-3 bound to some glycans term
23 high-mannose glycans, fucolsylated glycans, sialylated glycans, and hybrid structures were studied.
24 sm for a parietal cell-deficient niche where sialylated glycans are expressed by a narrow band of pit
26 Single-cell binding studies indicate that sialylated glycans are likely not required for initial a
27 tory pathway in which host-specific alpha2,6-sialylated glycans are recognized as markers of self.
28 demonstrate that different distributions of sialylated glycans are related to the metastatic propert
32 tissues and highlight a functional role for sialylated glycans as reovirus coreceptors in the CNS.
34 IL-6 secretion were enriched in ApoC-III, di-sialylated glycans at multiple A1AT glycosylation sites
37 The IgG1 Fc fragments containing complex sialylated glycans attached to the N-terminal Asn(221) s
39 ot only result in accurate identification of sialylated glycans but also improve the characterization
41 O) structure, we show ABH antigens stabilize sialylated glycan clusters on erythrocyte membranes uniq
42 ows for linkage specific characterization of sialylated glycans directly from the precursor mass but
44 ated glycan library covering the most common sialylated glycan epitopes was prepared in high yield an
48 process, including initial binding of IAV to sialylated glycans, fusion between the viral envelope an
50 itative binding affinity of HA to alpha2-->6 sialylated glycans (human receptors) is one of the impor
52 s revealed the importance of sialylation and sialylated glycans in breast cancer brain metastasis.
53 ring 3F-NeuAc to mice dramatically decreases sialylated glycans in cells of all tissues tested, inclu
54 NAc), were incorporated into fucosylated and sialylated glycans in several cancer cell lines, allowin
60 that each pathotype makes use of a different sialylated glycan ligand, with binding sites on opposite
61 ies on sialic acid recognition using a novel sialylated glycan microarray containing modified sialic
62 Our results demonstrate the utility of this sialylated glycan microarray to investigate the biologic
65 ory signalling, which in turn implicates the sialylated glycans of the antigen as key suppressive det
67 ventional influenza A viruses (IAVs) bind to sialylated glycans on host cell surfaces for attachment
68 serine-rich repeat (SRR) adhesins recognize sialylated glycans on human salivary, platelet, and plas
76 ies of the first six reported siglecs, using sialylated glycans presented in multivalent form, on syn
77 s in ionization efficiency among neutral and sialylated glycans prevent direct quantitative compariso
79 in the expression of truncated core 1-based sialylated glycans rather than the core 2-based glycans
80 Crystal structures of EV-D68 in complex with sialylated glycan receptor analogues show that they bind
82 pecificity of the viral hemagglutinin to the sialylated glycan receptors (in the human host) by use o
83 on surfaces, obstructing a groove that binds sialylated glycan receptors in many other polyomaviruses
84 go-potential gastric stem cells that express sialylated glycan receptors recognized by H. pylori adhe
85 sialylated glycans) to human-like (alpha2-6 sialylated glycans) receptors is believed to be associat
86 array approach to analyze the repertoire of sialylated glycans recognized by viruses from the same c
88 ay studies confirmed the binding of HMGB1 to sialylated glycan sequences typically found on plasma gl
90 2)v showed a predominant binding to alpha2-6-sialylated glycans, similar to human-adapted influenza A
94 vealed that LEC from human skin express more sialylated glycans than the corresponding blood endothel
95 binding to sialyl Lewis x (sLe(x)) and other sialylated glycans that decorate P selectin glycoprotein
96 which bound almost exclusively to alpha-2,6 sialylated glycans, the seal H3 bound preferentially to
98 hemagglutinin (HA) from avian-like (alpha2-3 sialylated glycans) to human-like (alpha2-6 sialylated g
99 cuous ligand of proteins with high levels of sialylated glycans typically produced by cancer cells.
101 tiates viral entry by engaging host receptor sialylated glycans via its receptor-binding site (RBS).
102 -R1 has not previously been shown to bind to sialylated glycans, we demonstrate that it preferentiall
103 entional IAVs rely on multivalent binding to sialylated glycans, we hypothesized that bat HA similarl
104 and alkaline BGE systems, the mobilities of sialylated glycans were shifted relative to nonsialylate
105 hibited significantly reduced binding to all sialylated glycans, whereas Gal-1 bound alpha2-3- but no
106 ly, we used a nonmetabolic approach to label sialylated glycans with an independent chemistry, enabli
108 for simultaneous profiling both neutral and sialylated glycans without derivatization or labeling.